Palomino Laboratories (PALX) Payables (2022 - 2025)
Palomino Laboratories (PALX) posted Payables of $55687.0 for Q4 2025, down 85.33% sequentially from $379702.0 in Q3 2025, and up 765.92% YoY from $6431.0 in Q4 2024.
Palomino Laboratories (PALX) Payables (2022 - 2025) Analysis & Trends
Palomino Laboratories has reported Payables for 4 years, with the latest figure at $55687.0 in Q4 2025.
- Quarterly Payables rose 765.92% year-over-year to $55687.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $55687.0 (up 765.92% YoY) and the FY2025 annual result came in at $55687.0, up 765.92% from the prior year.
- Payables declined to $55687.0 in Q4 2025 per PALX's latest filing, from $379702.0 in the prior quarter.
- Over five years, Payables peaked at $379702.0 in Q3 2025 and troughed at $6431.0 in Q4 2024.
- A 4-year average of $129543.3 and a median of $79621.0 in 2023 frame the typical range for Payables.
- The sharpest annual moves came in 2024 and 2025: Payables sank 91.92% in 2024, then surged 765.92% in 2025.
- Over 4 years, Payables stood at $12804.0 in 2022, then jumped by 521.84% to $79621.0 in 2023, then tumbled by 91.92% to $6431.0 in 2024, then soared by 765.92% to $55687.0 in 2025.
- According to Business Quant data, Payables over the past three periods registered $55687.0, $379702.0, and $60781.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55,687.00 |
| Sep 30, 2025 | 379,702.00 |
| Jun 30, 2025 | 60,781.00 |
| Mar 31, 2025 | 320,816.00 |
| Dec 31, 2024 | 6,431.00 |
| Sep 30, 2024 | 177,004.00 |
| Jun 30, 2024 | 154,158.00 |
| Mar 31, 2024 | 126,675.00 |
| Dec 31, 2023 | 79,621.00 |
| Sep 30, 2023 | 51,297.00 |
| Dec 31, 2022 | 12,804.00 |